Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Acta Neurochirurgica
Published in: Acta Neurochirurgica 12/2016

01-12-2016 | Case Report - Brain Tumors

Decision-making in a patient with cardiac arrest due to venous thromboembolism within 24 h after glioblastoma resection

Authors: D. Dubinski, S-Y. Won, M. Bruder, M-T. Forster, V. Seifert, C. Senft, J. Berkefeld, J. Mersmann

Published in: Acta Neurochirurgica | Issue 12/2016

Login to get access

Abstract

In the fulminant VTE form with cardiac arrest, systemic thrombolysis remains the most effective therapy. However, several contraindications restrict the use such as intracranial neoplasm or a recent history of intracranial surgery. Here, we report the case of a 59-year-old man who underwent glioblastoma resection and suffered from a fulminant pulmonary embolism with cardiac arrest. After CPR, continuous tPA infusion via an endovascularly placed pulmonary catheter was maintained over a period of 8 h. In this case, we report on our decision-making process and the use of local thrombolysis as a successful therapy in a patient with multiple contraindications.
Literature
1.
Bayram B, Oray N, Korkmaz E, Erdost HA, Gokmen N (2014) Massive pulmonary embolism and cardiac arrest; thrombolytic therapy in a patient with recent intracranial surgery and glioblastoma multiforme. Am J Emerg Med 32(11):1441CrossRefPubMed
2.
Brandes AA, Scelzi E, Salmistraro G, Ermani M, Carollo C, Berti F, Zampieri P, Baiocchi C, Fiorentino MV (1997) Incidence of risk of thromboembolism during treatment high-grade gliomas: a prospective study. Eur J Cancer 33(10):1592–1596CrossRefPubMed
3.
Chaichana KL, Pendleton C, Jackson C, Martinz-Gutierrez JC, Diaz-Stransky A, Aguayo J, Olivi A, Weingart J, Gallia G, Lim M, Brem H, Quinones-Hinojosa A (2013) Deep venous thrombosis and pulmonary embolisms in adult patients undergoing craniotomy for brain tumors. Neurol Res 35(2):206–211CrossRefPubMed
4.
Farge D, Debourdeau P, Beckers M, Baglin C, Bauersachs RM, Brenner B, Brilhante D, Falanga A, Gerotzafias GT, Heim N, Kakkar AK, Khorana AA, Lecumberri R, Mandala M, Marty M, Monreal M, Mousa SA, Noble S, Pabinger I, Prandoni P, Prins MH, Qari MH, Streiff MB, Syrigos K, Bounameaux H, Büller HR (2013) International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer. J Thromb Haemost 11(1):56–70CrossRefPubMed
5.
Goldhaber SZ, Visani L, De Rosa M (1999) Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet (London, England) 353(9162):1386–1389CrossRef
6.
Han S (2006) Thrombolytic therapy for massive pulmonary embolism in a patient with a known intracranial tumor. J Intensive Care Med 21(4):240–245CrossRefPubMed
7.
Jenkins EO, Schiff D, Mackman N, Key NS (2010) Venous thromboembolism in malignant gliomas. J Thromb Haemost 8(2):221–227CrossRefPubMed
8.
Kearon C, Akl EA, Comerota AJ, Prandoni P, Bounameaux H, Goldhaber SZ, Nelson ME, Wells PS, Gould MK, Dentali F, Crowther M, Kahn SR (2012) Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141(2 Suppl):e419S–e494SCrossRefPubMedPubMedCentral
9.
10.
Lyman GH, Khorana AA, Falanga A, Clarke-Pearson D, Flowers C, Jahanzeb M, Kakkar A, Kauder NM, Levine MN, Liebman H, Mendelson D, Raskob G, Somerfield MR, Thodiyil P, Trent D, Francis CW (2007) American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer. J Clin Oncol 25(34):5490–5505CrossRefPubMed
11.
Lyman GH, Khorana AA, Kuderer NM, Lee AY, Arcelus JI, Balaban EP, Clarke JM, Flowers CR, Francis CW, Gates LE, Kakkar AK, Key NS, Levine HA, Liebman HA, Tempero MA, Wong SL, Prestrud AA, Falanga A (2013) Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 31(17):2189–2204CrossRefPubMed
12.
Simanek R, Vormittag R, Hassler M, Roessler K, Schwarz M, Zielinski C, Pabinger I, Marosi C (2007) Venous thromboembolism and survival in patients with high-grade glioma. Neuro Oncol 9(2):89–95CrossRefPubMedPubMedCentral
13.
Streiff MB, Segal J, Grossman SA, Kickler TS, Weir EG (2004) ABO blood group is a potent risk factor for venous thromboembolism in patients with malignant gliomas. Cancer 100(8):1717–1723CrossRefPubMed
14.
Streiff MB, Ye X, Kickler TS, Desideri S, Jani J, Fisher J, Grossmann SA (2015) A prospective multicenter study of venous thromboembolism in patients with newly-diagnosed high-grade glioma: hazard rate and risk factors. J Neurooncol 124(2):299–305CrossRefPubMedPubMedCentral
15.
Torbicki A, Perrier A, Konstantinides S, Agnelli G, Galie N, Pruszczyk P, Bengel F, Brady AJB, Ferreira D, Janssens U, Klepetko W, Mayer E, Remy-Jardin M, Bassand JP (2008) Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J 29(18):2276–2315CrossRefPubMed
16.
Yust-Katz S, Mandel JJ, Wu J, Yuan Y, Webre C, Pawar TA, Lhadha HS, Gilbert MR, Armstrong TS (2015) Venous thromboembolism (VTE) and glioblastoma. J Neurooncol 124(1):87–94CrossRefPubMed
Metadata
Title
Decision-making in a patient with cardiac arrest due to venous thromboembolism within 24 h after glioblastoma resection
Authors
D. Dubinski
S-Y. Won
M. Bruder
M-T. Forster
V. Seifert
C. Senft
J. Berkefeld
J. Mersmann
Publication date
01-12-2016
Publisher
Springer Vienna
Published in
Acta Neurochirurgica / Issue 12/2016
Print ISSN: 0001-6268
Electronic ISSN: 0942-0940
DOI
https://doi.org/10.1007/s00701-016-2982-2

Other articles of this Issue 12/2016

Acta Neurochirurgica 12/2016 Go to the issue

Case Report - History of Neurosurgery

Biofilm-associated infection: the hidden face of cerebrospinal fluid shunt malfunction

Clinical Article - Vascular

Perioperative stroke after carotid endarterectomy: etiology and implications

Editorial (by Invitation)

The EANS Ethico-legal Committee finds the proposed head transplant project unethical

Clinical Article - Brain Injury

Can early clinical parameters predict post-traumatic pituitary dysfunction in severe traumatic brain injury?

Clinical Article - Abstract

Multimodal analysis to predict shunt surgery outcome of 284 patients with suspected idiopathic normal pressure hydrocephalus

Experimental Research - Functional

Factors predicting the outcome following surgical treatment of mesial temporal epilepsy due to mesial temporal sclerosis